Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1995-07-25
1997-03-25
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
A61K 3578
Patent
active
056141980
ABSTRACT:
A composition containing a Bowman-Birk Inhibitor for the treatment of inflammation is provided. Methods of using this composition in the treatment of IBD and hepatic inflammation are also provided.
REFERENCES:
patent: 4793996 (1988-12-01), Kennedy et al.
patent: 5217717 (1993-06-01), Kennedy et al.
Baturay et al., "Pyrene acts as a cocarcinogen with the carcinogens benzo[a]pyrene, .beta.-propiolactone and radiation in the induction of malignant transformation in cultured mouse fibroblasts; soybean extract containing the Bowman-Birk Inhibitor acts as an anticarcinogen," Cell Biology and Toxicology 1986, 2, 21-32.
Birk et al., "Separation of a tribolium-protease inhibitor from soybeans on a calcium column," Biochim. Biophys. Acta 1963, 67, 326-328.
Bowman, "Differentiation of Soy Bean Antitryptic Factors," Proc. Soc. Exptl. Med. 1946, 63, 547-550.
Bradford, "A rapid and sensitive method for the quantitiation of microgram quantities of protein utilizing the principle of protein-dye binding," Anal. Biochem. 1976, 72, 248-254.
Frenkel et al., "Chymotrypsin-specific protease inhibitors decrease H.sub.2 O.sub.2 formation by activated human polymorphonuclear leukocytes," Carcinogenesis 1987, 8(9), 1207-1212.
Kennedy et al., Anticarcinogenesis and Radiation Protection, edited by Cerutti et al., Plenum Pub. Co. 1987, pp. 285-295.
Messadi et al., "Inhibition of Oral Carcinogenesis by a Protease Inhibitor," JNCI 1986, 76, 447-452.
Perlmann et al., "Proteolytic Enzymes," Methods in Enzymology 1970, 19, 860-861.
St. Clair et al., "Suppression of Dimethylhydrazine-induced Carcinogenesis in Mice by Dietary Addition of the Bowman-Birk Protease Inhibitor," Cancer Res. 1990, 50, 580-586.
Weed et al., "Protection against dimethylhydrazine-induced adenomatous tumors of the mouse colon by the dietary addition of an extract of soybeans containing the Bowman-Birk protease inhibitor," Carcinogenesis 1985, 6, 1239-1241.
Yavelow et al., "Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro," Proc. Natl. Acad. Sci. USA 1985, 82, 5395-5399.
Yavelow et al., "Bowman-Birk soybean protease inhibitor as an anticarcinogen," Cancer Res. 1983, 43, 2454-2459.
Billings Paul C.
Kennedy Ann R.
Henley III Raymond
The Trustees of the University of Pennsylvania
LandOfFree
Bowman-Birk Inhibitor compositions for treatment of inflammatory does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bowman-Birk Inhibitor compositions for treatment of inflammatory, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bowman-Birk Inhibitor compositions for treatment of inflammatory will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2201147